Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4582486
Max Phase: Preclinical
Molecular Formula: C41H53F2N7O9
Molecular Weight: 825.91
Molecule Type: Unknown
Associated Items:
ID: ALA4582486
Max Phase: Preclinical
Molecular Formula: C41H53F2N7O9
Molecular Weight: 825.91
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCc1ccc(NC(=O)N[C@@H](Cc2cc(F)cc(F)c2)C(=O)N[C@@H]2C(=O)N3CCC[C@H]3C(=O)N(C)[C@@H]([C@H](C)O)C(=O)N[C@@H](C)C(=O)N3C[C@H](C)C[C@H]3C(=O)O[C@H]2C)cc1
Standard InChI: InChI=1S/C41H53F2N7O9/c1-7-25-10-12-29(13-11-25)45-41(58)46-30(18-26-16-27(42)19-28(43)17-26)35(52)47-33-24(5)59-40(57)32-15-21(2)20-50(32)37(54)22(3)44-36(53)34(23(4)51)48(6)38(55)31-9-8-14-49(31)39(33)56/h10-13,16-17,19,21-24,30-34,51H,7-9,14-15,18,20H2,1-6H3,(H,44,53)(H,47,52)(H2,45,46,58)/t21-,22+,23+,24+,30+,31+,32+,33+,34+/m1/s1
Standard InChI Key: DEBVNRXWDWZPCH-XBZUMIDTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 825.91 | Molecular Weight (Monoisotopic): 825.3873 | AlogP: 1.63 | #Rotatable Bonds: 8 |
Polar Surface Area: 206.79 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 16 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.07 | CX Basic pKa: | CX LogP: 1.90 | CX LogD: 1.90 |
Aromatic Rings: 2 | Heavy Atoms: 59 | QED Weighted: 0.25 | Np Likeness Score: 0.18 |
1. (2018) Substituted urea depsipeptide analogs as activators of the clpp endopeptidase, |
Source(1):